You are here

Home / Our Funding / Where our funding goes / Institutions we've funded / University of California, Los Angeles
  • Share
  • Print

University of California, Los Angeles

Total Awards: 
60
ICOC Committed funds: 
188 470 196

Awards to the Institution

Funding
Basic Biology III: Kathrin Plath Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells $1,364,598
Basic Biology III: Gay Crooks Forming the Hematopoietic Niche from Human Pluripotent Stem Cells $1,375,983
Basic Biology III: Ali Nsair Characterization and Engineering of the Cardiac Stem Cell Niche $1,181,306
Basic Biology III: William Lowry Molecular determinants of accurate differentiation from human pluripotent stem cells $1,354,230
Basic Biology III: Shuo Lin Etsrp/ER71 mediated stem cell differentiation into vascular lineage $1,382,400
Basic Biology III: Yi Sun Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo $1,382,400
New Faculty II: Antoni Ribas Stem Cells for Immune System Regeneration to Fight Cancer $3,247,000
New Faculty II: Brigitte Gomperts Stem Cells in Lung Cancer $2,556,572
New Cell Lines: Zack Jerome Generation of clinical grade human iPS cells $1,382,400
New Cell Lines: Amander Clark Generation of Pluripotent Cell Lines from Human Embryos $1,177,648
Tools and Technologies II: Richard Gatti Use of hiPSCs to develop lead compounds for the treatment of genetic diseases $1,833,054
Tools and Technologies II: Stanley Carmichael Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke $1,825,613
Tools and Technologies II: Martin Martin Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders $1,783,250
Early Translational II: Noriyuki Kasahara Stem cell-based carriers for RCR vector delivery to glioblastoma $3,370,607
Early Translational II: Sophie Deng Regeneration of Functional Human Corneal Epithelial Progenitor Cells $1,654,058
Early Translational II: Bruno Peault Harnessing native fat-residing stem cells for bone regeneration $5,391,560
Basic Biology II: Douglas Black Programs of alternative splicing regulation by polypyrimidine tract binding protein $1,350,994
Basic Biology II: Yong Kim Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells $1,259,371
Basic Biology II: Benhur Lee The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation $1,371,936
Disease Team Research I: Dennis Slamon THERAPEUTIC OPPORTUNITIES TO TARGET TUMOR INITIATING CELLS IN SOLID TUMORS $19,979,660
Disease Team Research I: Donald Kohn Stem Cell Gene Therapy for Sickle Cell Disease $9,212,365
Disease Team Research I: Irvin Chen HPSC based therapy for HIV disease using RNAi to CCR5. $9,905,604
Basic Biology I: Robb Maclellan Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate $1,378,076
Basic Biology I: Luisa Iruela-Arispe Molecular Characterization and Functional Exploration of Hemogenic Endothelium $1,371,477
Basic Biology I: Bennett Novitch Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons $1,363,262
Basic Biology I: Michael Teitell Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer $1,323,029
Research Training II: Kenneth Dorshkind CIRM Research Training Program II $7,982,293
Tools and Technologies I: Michael Phelps Novel Tools and Technologies for Translational PET Imaging of Cell-based Therapies $914,096
Tools and Technologies I: Hsian-Rong Tseng Microfluidic Platform for Screening Chemically Defined Conditions that Facilitate Clonal Expansion of Human Pluripotent Stem Cells $914,096
New Faculty I: Dana Jones Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $2,675,234
Total:
$93,264,172.00

Pages

Icon for xls export

© 2013 California Institute for Regenerative Medicine